ESCs provide an in vitro platform that can reduce reliance on animal testing, aligning with the 3Rs principle of replacement, reduction, and refinement in animal research. They offer a human-relevant model that can provide more accurate data on human-specific toxic responses. ESC-based assays can be standardized and scaled up for high-throughput screening, making them suitable for assessing a large number of compounds efficiently.
